Keros Therapeutics KROS
NASDAQ KROS
$11.03 +0.08 (+0.73%)
At close: Aug 21, 2026 · 4:00 PM EDT

Keros Therapeutics (KROS) Prepaid Assets (2019 - 2026)

Keros Therapeutics' (KROS) quarterly Prepaid Assets came in at $2.4 million in Q4 2025, down 90.86% YoY from $26.2 million in Q4 2024, and down 89.27% on a QoQ basis from $22.3 million in Q3 2025.

Keros Therapeutics (KROS) Prepaid Assets (2019 - 2026) Analysis & Trends

Keros Therapeutics (KROS) has 7 years of Prepaid Assets data on file, last reported at $2.4 million in Q4 2025.

  • Quarterly Prepaid Assets fell 90.86% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (down 90.86% YoY) and the FY2025 annual result came in at $2.4 million, down 90.86% from the prior year.
  • Prepaid Assets fell to $2.4 million in Q4 2025, from $22.3 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $26.8 million in Q2 2024 to a low of $210000.0 in Q4 2021.
  • A 5-year average of $10.8 million and a median of $5.7 million in 2021 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2024 — Prepaid Assets jumped 7040.16% — and 2025, when it sank 90.86%.
  • Tracing KROS's Prepaid Assets over 5 years: stood at $210000.0 in 2021, then surged by 3099.52% to $6.7 million in 2022, then plunged by 85.1% to $1.0 million in 2023, then surged by 2519.38% to $26.2 million in 2024, then slumped by 90.86% to $2.4 million in 2025.
  • The last three Prepaid Assets figures came in at $2.4 million (Q4 2025), $22.3 million (Q3 2025), and $26.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Keros Therapeutics 217.61 Mn -40.00 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 7.03 Mn
Dec 31, 2025 2.40 Mn
Sep 30, 2025 22.34 Mn
Jun 30, 2025 26.78 Mn
Mar 31, 2025 21.68 Mn
Dec 31, 2024 26.22 Mn
Sep 30, 2024 20.97 Mn
Jun 30, 2024 26.85 Mn
Mar 31, 2024 20.46 Mn
Dec 31, 2023 1.00 Mn
Sep 30, 2023 16.54 Mn
Jun 30, 2023 376,000.00
Mar 31, 2023 10.79 Mn
Dec 31, 2022 6.72 Mn
Sep 30, 2022 745,000.00
Jun 30, 2022 466,000.00
Mar 31, 2022 2.63 Mn
Dec 31, 2021 210,000.00
Sep 30, 2021 4.73 Mn
Jun 30, 2021 4.20 Mn